Neuromyelitis optica (NMOSD) trials in China

30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Early phase 1Not yet taking people in China
  Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

  Where

  Beijing

  Age

  18 years to 75 years

  People

  25

  Run by

  Xuanwu Hospital, Beijing

  See details and how to joinNCT06485232
• Phase 2Taking people
  A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

  Where

  Changsha

  Age

  18 years to 65 years

  People

  35

  Run by

  Guangzhou JOYO Pharma Co., Ltd

  See details and how to joinNCT06697535
• Early phase 1Taking people
  Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

  Where

  Wuhan

  Age

  18 years to 75 years

  People

  36

  Run by

  Tongji Hospital

  See details and how to joinNCT04561557
• No phaseTaking people
  Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

  Where

  Wuhan

  Age

  18 years and over

  People

  250

  Run by

  Tongji Hospital

  See details and how to joinNCT06474520
• No phaseTaking people
  Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

  Where

  Guangzhou

  Age

  18 years to 65 years

  People

  450

  Run by

  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  See details and how to joinNCT06541626